FBT · First Trust
First Trust NYSE Arca Biotechnology Index Fund
See how 32 reported holdings combine into this ETF’s P/E and P/S. Market value, signed ordinary earnings and revenue are added before each ratio is calculated.
Core valuation
Coverage is the share of positive eligible-equity holding value represented in each metric. The published holdings account for 100.06% of fund weight. The reliability standard requires at least 90.00% disclosed fund weight and metric coverage, with no individual uncovered holding above 1.00%.
Largest reported holdings
| Holding | Weight | Trailing P/E | Trailing P/S |
|---|---|---|---|
| CORTCORCEPT THERAPEUTICS INC COM | 5.60% | 227.37× | 14.84× |
| NEONEOGENOMICS INC COM NEW | 5.12% | -44.03× | 2.98× |
| VCYTVERACYTE INC COM | 5.10% | 31.03× | 6.32× |
| BRKRBRUKER CORP COM | 4.32% | -87.91× | 2.69× |
| ALKSALKERMES PLC SHS | 4.24% | 102.86× | 4.08× |
| ILMNILLUMINA INC COM | 3.92% | 48.63× | 8.93× |
| KRYSKRYSTAL BIOTECH INC COM | 3.87% | 39.88× | 21.86× |
| NTRANATERA INC COM | 3.79% | -306.11× | 21.75× |
| AXSMAXSOME THERAPEUTICS INC COM | 3.71% | -49.76× | 12.28× |
| NBIXNEUROCRINE BIOSCIENCES INC COM | 3.53% | 20.27× | 4.24× |
Top 10 of 32 reported holdings. * A holding uses its latest full-year result only when both trailing and latest-quarter inputs are unavailable; open the stock for the exact year end.
Most similar funds
Ranked by shared weight across matching disclosed company holdings and explicitly reported same-currency cash.
- IBBQ · Invesco Nasdaq Biotechnology ETF44.83% holdings overlap · US market
- PBE · Invesco Biotechnology & Genome ETF44.83% holdings overlap · US market
- BBH · VanEck Biotech ETF40.98% holdings overlap · Nasdaq
- IBB · iShares Biotechnology ETF39.23% holdings overlap · US market
- GNOM · Global X Genomics & Biotechnology ETF30.53% holdings overlap · Nasdaq
Sources and limitations
Holdings are sourced from First Trust and company financial inputs retain primary-source links. Monetary values are normalised to USD. Corporate actions, reporting lags, unmapped securities and cash can create differences from provider figures.
Open official holdings sourceResearch holdings date: 30 June 2026. Informational research, not investment advice.